| Literature DB >> 26099274 |
Aduragbemi Oluwabusayo Banke-Thomas1, Barbara Madaj2, Ameh Charles3, Nynke van den Broek4.
Abstract
BACKGROUND: Increased scarcity of public resources has led to a concomitant drive to account for value-for-money of interventions. Traditionally, cost-effectiveness, cost-utility and cost-benefit analyses have been used to assess value-for-money of public health interventions. The social return on investment (SROI) methodology has capacity to measure broader socio-economic outcomes, analysing and computing views of multiple stakeholders in a singular monetary ratio. This review provides an overview of SROI application in public health, explores lessons learnt from previous studies and makes recommendations for future SROI application in public health.Entities:
Mesh:
Year: 2015 PMID: 26099274 PMCID: PMC4477315 DOI: 10.1186/s12889-015-1935-7
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Comparison of SROI with traditional economic evaluation frameworks
| Cost-Effectiveness Analysis (CEA) | Cost-Utility Analysis (CUA) Sub-type of CEA | Cost-Benefit Analysis (CBA) | Social Return on Investment (SROI) |
|---|---|---|---|
| Main objective | |||
| To compare costs and impact of alternatives within the same domain | To compare costs and impact of alternatives within the same domain | To assess if an intervention is worth the investment. | To assess if an intervention is worth the investment. |
| Costs | |||
| Monetary value | Monetary value | Monetary value | Monetary value |
| Benefits | |||
| Benefits linked to health improvements. | Benefits linked to health improvements. | Captures health and non-health impacts. | Captures health and non-health impacts, underpinned by the “triple bottom line” approach (social, economic and environmental). In addition, seeks to account for and value potential negative effect of interventions. |
| Reported as natural units E.g. lives saved or cases averted | Reported as Quality Adjusted Life Years (QALYs) gained/ Disability Adjusted Life Years (DALYs) averted/ Healthy life-years gained | Reported as monetary value or welfare benefit | Reported as monetary value or welfare benefit |
| Lists benefits that cannot be easily monetised and explains why they cannot be monetised | Uses financial proxies to estimate monetary value of benefits that cannot be easily monetised | ||
| Level of application | |||
| Intervention level | Intervention level | Usually intervention level | Intervention, project, programme, policy or organisation level |
| Timeline of analysis | |||
| Retrospective or Prospective | Retrospective or Prospective | Retrospective or Prospective | Retrospective or Prospective |
| Discounting of future value | |||
| Yes | Yes | Yes | Yes |
| Stakeholder engagement | |||
| No | No | No | Yes |
| Theory of change | |||
| No | No | No | Yes |
| Main output of analysis | |||
| Incremental Cost-Effectiveness Ratio (ICER) | Incremental Cost-Effectiveness Ratio (ICER) | Benefit-Cost Ratio (BCR) | Social Return on Investment Ratio |
| Economic Internal Rate of Return (EIRR) | Net Present Value (NPV) | ||
| Net Present Value (NPV) | Payback period | ||
| Break-even point | |||
| Interpretation of main output of analysis | |||
| Intervention with higher cost-effectiveness ratio is better | Intervention with higher cost-effectiveness ratio is better | BCR > 1 is worthwhile investment | SROI ratio > 1 is worthwhile investment |
| Relevance | |||
| Priority setting and resource allocation | Priority setting and resource allocation | Priority setting and resource allocation | Priority setting |
| Resource allocation | |||
| Stakeholder relationship building, | |||
| Accountability framework, Management tool | |||
Fig. 1Stages of the SROI process
Krlev et al’s 12-point quality assessment framework
| Dimension number | Dimension | Criterion | Description of criterion |
|---|---|---|---|
| I | Transparency about why SROI was chosen | 1 | Linked to context discussion? |
| II | Documentation of the analysis | 2 | Analysis well documented? |
| 3 | Impact map used? | ||
| III | Study design (approximation of ‘dead-weight’) | 4 | Control group setup applied? |
| 5 | Ex ante - ex post observations performed? | ||
| IV | Precision of the analysis | 6 | Indicators valid & comprehensive? |
| 7 | Proxies valid & comprehensive? | ||
| 8 | Social effects captured? (Qualitatively) | ||
| 9 | Social effects captured? (Quantitatively) | ||
| V | Reflection of the results | 10 | Limitations discussed? |
| 11 | SROI ratio interpreted? | ||
| 12 | Sensitivity analysis performed? |
Fig. 2PRISMA flowchart summarising the search process
Fig. 3Number of studies published by year in countries where SROI has been applied
Findings from systematic review of SROI application in Public Health
| Study characteristics | Number of studies | % of total |
|---|---|---|
| SROI type | ||
| Evaluative type | 26 | 65.00 |
| Forecast type | 14 | 35.00 |
| Area of Public Health | ||
| Child Health | 4 | 10.00 |
| Environmental Health | 1 | 2.50 |
| Health Care Management | 2 | 5.00 |
| Health Education | 1 | 2.50 |
| Health Promotion | 12 | 30.00 |
| Mental Health | 11 | 27.50 |
| Nutrition | 3 | 7.50 |
| Sexual Reproductive Health | 6 | 15.00 |
| Stakeholders included | ||
| Only beneficiaries | 21 | 52.50 |
| Beneficiaries and implementers | 3 | 7.50 |
| Beneficiaries and promoters | 2 | 5.00 |
| Beneficiaries, implementers and promoters | 3 | 7.50 |
| All stakeholders | 11 | 27.50 |
| Data Source | ||
| Qualitative alone | 3 | 7.50 |
| Qualitative + primary | 8 | 20.50 |
| Qualitative + secondary | 9 | 22.50 |
| Qualitative + primary + secondary | 15 | 37.50 |
| Quantitative (primary) alone | 1 | 2.50 |
| Quantitative (secondary) alone | 3 | 7.50 |
| Quantitative (primary + secondary) | 1 | 2.50 |
Range of SROI ratios by Public Health area
| Public health area | Minimum SROI ratio | Maximum SROI ratio |
|---|---|---|
| Child Health | 1.85 | 65.00 |
| Environmental Healtha | 26.00 | 26.00 |
| Health Care Management | 1.98 | 7.00 |
| Health Educationa | 7.25 | 7.25 |
| Health Promotion | 1.10 | 11.00 |
| Mental Health | 1.57 | 11.91 |
| Nutrition | 2.05 | 5.28 |
| Sexual Reproductive Health | 1.73 | 21.20 |
aOnly one included study